{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:41:04Z","timestamp":1791909664606,"version":"4.3.4"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>HBV covalently closed circular DNA (cccDNA) is a major obstacle for a cure of chronic hepatitis B. Accumulating evidence suggests that epigenetic modifications regulate the transcriptional activity of cccDNA minichromosomes. However, it remains unclear how the epigenetic state of cccDNA affects its stability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Approaches and Results<\/jats:title>\n                    <jats:p>By using HBV infection cell models and in vitro and in vivo recombinant cccDNA (rcccDNA) and HBVcircle models, the reduction rate of HBV cccDNA and the efficacy of apolipoprotein B mRNA editing enzyme catalytic subunit 3A (APOBEC3A)\u2013mediated and CRISPR\/CRISPR\u2010associated 9 (Cas9)\u2013mediated cccDNA targeting were compared between cccDNAs with distinct transcriptional activities. Interferon\u2010\u03b1 treatment and hepatitis B x protein (HBx) deletion were applied as two strategies for cccDNA repression. Chromatin immunoprecipitation and micrococcal nuclease assays were performed to determine the epigenetic pattern of cccDNA. HBV cccDNA levels remained stable in nondividing hepatocytes; however, they were significantly reduced during cell division, and the reduction rate was similar between cccDNAs in transcriptionally active and transcriptionally repressed states. Strikingly, HBV rcccDNA without HBx expression exhibited a significantly longer persistence in mice. The cccDNA with low transcriptional activity exhibited an epigenetically inactive pattern and was more difficult to access by APOBEC3A and engineered CRISPR\u2010Cas9. The epigenetic regulator activating cccDNA increased its vulnerability to APOBEC3A.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HBV cccDNA minichromosomes in distinct epigenetic transcriptional states showed a similar reduction rate during cell division but significantly differed in their accessibility and vulnerability to targeted nucleases and antiviral agents. Epigenetic sensitization of cccDNA makes it more susceptible to damage and may potentially contribute to an HBV cure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.32245","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T03:54:12Z","timestamp":1636948452000},"page":"1275-1288","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":35,"title":["HBV covalently closed circular DNA minichromosomes in distinct epigenetic transcriptional states differ in their vulnerability to damage"],"prefix":"10.1097","volume":"75","author":[{"given":"Yang","family":"Wang","sequence":"first","affiliation":[{"name":"Key Laboratory of Medical Molecular Virology (MOE\/NHC\/CAMS),School of Basic Medical Sciences,Shanghai Medical College,Fudan University,Shanghai,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of Medical Molecular Virology (MOE\/NHC\/CAMS),School of Basic Medical Sciences,Shanghai Medical College,Fudan University,Shanghai,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zai","sequence":"additional","affiliation":[{"name":"Key Laboratory of Medical Molecular Virology (MOE\/NHC\/CAMS),School of Basic Medical Sciences,Shanghai Medical College,Fudan University,Shanghai,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kongying","family":"Hu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Medical Molecular Virology (MOE\/NHC\/CAMS),School of Basic Medical Sciences,Shanghai Medical College,Fudan University,Shanghai,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Medical Molecular Virology (MOE\/NHC\/CAMS),School of Basic Medical Sciences,Shanghai Medical College,Fudan University,Shanghai,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Deng","sequence":"additional","affiliation":[{"name":"Key Laboratory of Medical Molecular Virology (MOE\/NHC\/CAMS),School of Basic Medical Sciences,Shanghai Medical College,Fudan University,Shanghai,China"},{"name":"Research Unit of Cure of Chronic Hepatitis B Virus Infection,Chinese Academy of Medical Sciences,Shanghai,China"},{"name":"Shanghai Frontiers Science Center of Pathogenic Microbes and Infection,Shanghai,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wu","sequence":"additional","affiliation":[{"name":"Shanghai Public Health Clinical Center,Fudan University,Shanghai,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaming","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of Medical Molecular Virology (MOE\/NHC\/CAMS),School of Basic Medical Sciences,Shanghai Medical College,Fudan University,Shanghai,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieliang","family":"Chen","sequence":"additional","affiliation":[{"name":"Key Laboratory of Medical Molecular Virology (MOE\/NHC\/CAMS),School of Basic Medical Sciences,Shanghai Medical College,Fudan University,Shanghai,China"},{"name":"Research Unit of Cure of Chronic Hepatitis B Virus Infection,Chinese Academy of Medical Sciences,Shanghai,China"},{"name":"Shanghai Frontiers Science Center of Pathogenic Microbes and Infection,Shanghai,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghong","family":"Yuan","sequence":"additional","affiliation":[{"name":"Key Laboratory of Medical Molecular Virology (MOE\/NHC\/CAMS),School of Basic Medical Sciences,Shanghai Medical College,Fudan University,Shanghai,China"},{"name":"Research Unit of Cure of Chronic Hepatitis B Virus Infection,Chinese Academy of Medical Sciences,Shanghai,China"},{"name":"Shanghai Frontiers Science Center of Pathogenic Microbes and Infection,Shanghai,China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,14]]},"reference":[{"key":"hep32245-bib-0001-20250824","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2468-1253(19)30119-0","article-title":"A global scientific strategy to cure hepatitis B","volume":"4","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"hep32245-bib-0002-20250824","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","year":"2015","journal-title":"Gut"},{"key":"hep32245-bib-0003-20250824","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/v9060156","article-title":"The role of cccDNA in HBV maintenance","volume":"9","year":"2017","journal-title":"Viruses"},{"key":"hep32245-bib-0004-20250824","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"343","year":"2014","journal-title":"Science"},{"key":"hep32245-bib-0005-20250824","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","article-title":"Interferon\u2010\u03b3 and tumor necrosis factor\u2010\u03b1 produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis","volume":"150","year":"2016","journal-title":"Gastroenterology"},{"key":"hep32245-bib-0006-20250824","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF01703079","article-title":"Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell","volume":"8","year":"1994","journal-title":"Virus Genes"},{"key":"hep32245-bib-0007-20250824","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/jmbi.2000.4481","article-title":"Structural organization of the hepatitis B virus minichromosome","volume":"307","year":"2001","journal-title":"J Mol Biol"},{"key":"hep32245-bib-0008-20250824","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00281-020-00780-6","article-title":"Epigenetic modulation in chronic hepatitis B virus infection","volume":"42","year":"2020","journal-title":"Semin Immunopathol"},{"key":"hep32245-bib-0009-20250824","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.gastro.2006.01.001","article-title":"Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA\u2010bound H3 and H4 histones","volume":"130","year":"2006","journal-title":"Gastroenterology"},{"key":"hep32245-bib-0010-20250824","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/hep.29133","article-title":"PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation","volume":"66","year":"2017","journal-title":"Hepatology"},{"key":"hep32245-bib-0011-20250824","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/hep.29912","article-title":"SIRT3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3\u20139 homolog 1 and SET domain containing 1A histone methyltransferases","volume":"68","year":"2018","journal-title":"Hepatology"},{"key":"hep32245-bib-0012-20250824","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI58847","article-title":"IFN\u2010alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome","volume":"122","year":"2012","journal-title":"J Clin Invest"},{"key":"hep32245-bib-0013-20250824","article-title":"Alpha\u2010interferon suppresses hepadnavirus transcription by altering epigenetic modification of cccDNA minichromosomes","volume":"9","year":"2013","journal-title":"PLoS Pathog"},{"key":"hep32245-bib-0014-20250824","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.gde.2008.01.021","article-title":"Epigenetic regulation of heterochromatic DNA stability","volume":"18","year":"2008","journal-title":"Curr Opin Genet Dev"},{"key":"hep32245-bib-0015-20250824","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.gastro.2018.06.093","article-title":"Cell and animal models for studying hepatitis B virus infection and drug development","volume":"156","year":"2019","journal-title":"Gastroenterology"},{"key":"hep32245-bib-0016-20250824","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/hep.29609","article-title":"Hepatitis B virus sensitivity to interferon\u2010alpha in hepatocytes is more associated with cellular interferon response than with viral genotype","volume":"67","year":"2018","journal-title":"Hepatology"},{"key":"hep32245-bib-0017-20250824","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/hep.31282","article-title":"Functional comparison of interferon\u2010\u03b1 subtypes reveals potent hepatitis B virus suppression by a concerted action of interferon\u2010\u03b1 and interferon\u2010\u03b3 signaling","volume":"73","year":"2021","journal-title":"Hepatology"},{"key":"hep32245-bib-0018-20250824","doi-asserted-by":"crossref","first-page":"12472","DOI":"10.1128\/JVI.01123-07","article-title":"Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation","volume":"81","year":"2007","journal-title":"J Virol"},{"key":"hep32245-bib-0019-20250824","doi-asserted-by":"crossref","first-page":"8045","DOI":"10.1128\/JVI.01024-14","article-title":"Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice","volume":"88","year":"2014","journal-title":"J Virol"},{"key":"hep32245-bib-0020-20250824","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/hep.29406","article-title":"Recombinant covalently closed circular DNA of hepatitis B virus induces long\u2010term viral persistence with chronic hepatitis in a mouse model","volume":"67","year":"2018","journal-title":"Hepatology"},{"key":"hep32245-bib-0021-20250824","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jhep.2017.02.004","article-title":"HBVcircle: a novel tool to investigate hepatitis B virus covalently closed circular DNA","volume":"66","year":"2017","journal-title":"J Hepatol"},{"key":"hep32245-bib-0022-20250824","doi-asserted-by":"crossref","first-page":"9392","DOI":"10.1128\/jvi.71.12.9392-9399.1997","article-title":"Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus","volume":"71","year":"1997","journal-title":"J Virol"},{"key":"hep32245-bib-0023-20250824","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2015.08.005","article-title":"Metabolism and function of hepatitis B virus cccDNA: implications for the development of cccDNA\u2010targeting antiviral therapeutics","volume":"122","year":"2015","journal-title":"Antiviral Res"},{"key":"hep32245-bib-0024-20250824","doi-asserted-by":"crossref","first-page":"17780","DOI":"10.1073\/pnas.0508913102","article-title":"Dynamics of hepatitis B virus clearance in chimpanzees","volume":"102","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"hep32245-bib-0025-20250824","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/gutjnl-2016-312162","article-title":"Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo","volume":"67","year":"2018","journal-title":"Gut"},{"key":"hep32245-bib-0026-20250824","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jhep.2015.06.023","article-title":"HBx relieves chromatin\u2010mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"hep32245-bib-0027-20250824","doi-asserted-by":"crossref","first-page":"19975","DOI":"10.1073\/pnas.0908365106","article-title":"Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function","volume":"106","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"hep32245-bib-0028-20250824","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature17170","article-title":"Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor","volume":"531","year":"2016","journal-title":"Nature"},{"key":"hep32245-bib-0029-20250824","first-page":"E5715","article-title":"Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation","volume":"112","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"hep32245-bib-0030-20250824","doi-asserted-by":"crossref","first-page":"10059","DOI":"10.1128\/JVI.00535-12","article-title":"Characterization of nucleosome positioning in hepadnaviral covalently closed circular DNA minichromosomes","volume":"86","year":"2012","journal-title":"J Virol"},{"key":"hep32245-bib-0031-20250824","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1128\/jvi.69.6.3350-3357.1995","article-title":"The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes","volume":"69","year":"1995","journal-title":"J Virol"},{"key":"hep32245-bib-0032-20250824","article-title":"Targeting hepatitis B virus with CRISPR\/Cas9","volume":"3","year":"2014","journal-title":"Mol Ther Nucleic Acids"},{"key":"hep32245-bib-0033-20250824","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/genes9040207","article-title":"Gene therapy for chronic HBV\u2014can we eliminate cccDNA?","volume":"9","year":"2018","journal-title":"Genes (Basel)"},{"key":"hep32245-bib-0034-20250824","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/hep.29479","article-title":"Epigenetic regulation of hepatitis B virus covalently closed circular DNA: implications for epigenetic therapy against chronic hepatitis B","volume":"66","year":"2017","journal-title":"Hepatology"},{"key":"hep32245-bib-0035-20250824","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/hep.26718","article-title":"Chemotherapy\u2010induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study","volume":"59","year":"2014","journal-title":"Hepatology"},{"key":"hep32245-bib-0036-20250824","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/nm1096-1104","article-title":"The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T\u2010lymphocyte response","volume":"2","year":"1996","journal-title":"Nat Med"},{"key":"hep32245-bib-0037-20250824","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1053\/j.gastro.2004.03.018","article-title":"Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy","volume":"126","year":"2004","journal-title":"Gastroenterology"},{"key":"hep32245-bib-0038-20250824","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/hep.31240","article-title":"Rapid turnover of hepatitis B virus covalently closed circular DNA indicated by monitoring emergence and reversion of signature\u2010mutation in treated chronic hepatitis B patients","volume":"73","year":"2021","journal-title":"Hepatology"},{"key":"hep32245-bib-0039-20250824","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/hep.31516","article-title":"Analysis of hepatitis B virus haplotype diversity detects striking sequence conservation across genotypes and chronic disease phase","volume":"73","year":"2021","journal-title":"Hepatology"},{"key":"hep32245-bib-0040-20250824","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1172\/JCI83339","article-title":"In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection","volume":"126","year":"2016","journal-title":"J Clin Invest"},{"key":"hep32245-bib-0041-20250824","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jhep.2016.05.014","article-title":"Decay of ccc\u2010DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV\u2010HBV co\u2010infected patients","volume":"65","year":"2016","journal-title":"J Hepatol"},{"key":"hep32245-bib-0042-20250824","article-title":"Hepatitis B viral DNA decline at loss of HBeAg is mainly explained by reduced cccDNA load\u2013down\u2010regulated transcription of pgRNA has limited impact","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"hep32245-bib-0043-20250824","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.284.5415.825","article-title":"Viral clearance without destruction of infected cells during acute HBV infection","volume":"284","year":"1999","journal-title":"Science"},{"key":"hep32245-bib-0044-20250824","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jhep.2016.02.009","article-title":"Attacking hepatitis B virus cccDNA\u2014the holy grail to hepatitis B cure","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"hep32245-bib-0045-20250824","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jhep.2021.05.013","article-title":"Covalently closed circular DNA: the ultimate therapeutic target for curing HBV infections","volume":"75","year":"2021","journal-title":"J Hepatol"},{"key":"hep32245-bib-0046-20250824","article-title":"Distribution of hepatitis B virus nuclear DNA","volume":"92","year":"2018","journal-title":"J Virol"},{"key":"hep32245-bib-0047-20250824","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/mt.2013.212","article-title":"An efficient antiviral strategy for targeting hepatitis B virus genome using transcription activator\u2013like effector nucleases","volume":"22","year":"2014","journal-title":"Mol Ther"},{"key":"hep32245-bib-0048-20250824","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0140-6736(20)30264-6","article-title":"Kick and kill for HIV latency","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"hep32245-bib-0049-20250824","article-title":"Therapeutic shutdown of HBV transcripts promotes reappearance of the SMC5\/6 complex and silencing of the viral genome in vivo","year":"2021","journal-title":"Gut"},{"key":"hep32245-bib-0050-20250824","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jhep.2020.09.019","article-title":"Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx","volume":"74","year":"2021","journal-title":"J Hepatol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep.32245","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep.32245","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.32245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T23:06:58Z","timestamp":1756076818000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.32245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,14]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.32245","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,14]]},"assertion":[{"value":"2021-06-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}